P rotein phosphorylation is a ubiquitous regulatory mechanism that affects almost every cellular process 1, 2 . Phosphoryl groups, typically originating from ATP, are attached to amino acid side chains on protein substrates by protein kinases and removed by protein phosphatases, resulting in reversible regulation on a shorter time scale than that allowed by transcriptional responses 3, 4 . While phosphorylation can directly alter the activity of a modified protein, it often exerts its effects by creating docking sites for phospho-binding domains, thus initiating new protein-protein interactions 5, 6 . Phosphorylation-based signal transduction systems are therefore best thought of as tripartite toolkits composed of writers (protein kinases), erasers (protein phosphatases), and phosphobinding domains that serve as downstream readers 7 . However, this nomenclature has rarely been used to describe protein phosphorylation cascades in bacteria, where phospho-binding domains are scarce 8 and phosphorylation is thought to mainly directly control the function of specific transcription factors, as exemplified by the two-component regulatory system 9 . With hundreds of phosphoarginine (pArg) sites detected in Bacillus subtilis [10] [11] [12] [13] and Staphylococcus aureus 14, 15 , protein arginine phosphorylation of Gram-positive bacteria is emerging as a novel, major example of a phosphorylation-based signaling system, with established links to stress response and pathogenicity [16] [17] [18] [19] . Arginine side chains are phosphorylated by McsB and dephosphorylated by YwlE, both of which can distinguish (phospho)arginine from other amino acid residues 20, 21 . Although the structure of McsB has remained elusive, sequence analysis has demonstrated that it is unrelated to canonical protein kinases and instead shows weak homology to PhKs, metabolic enzymes exemplified by human creatine kinases and insect arginine kinases [22] [23] [24] . In the species in which it is found, McsB does not have any further sequence homologs and appears to be the only protein arginine kinase, as knocking out its gene abolishes all detectable pArg sites in B. subtilis 11 .
. While phosphorylation can directly alter the activity of a modified protein, it often exerts its effects by creating docking sites for phospho-binding domains, thus initiating new protein-protein interactions 5, 6 . Phosphorylation-based signal transduction systems are therefore best thought of as tripartite toolkits composed of writers (protein kinases), erasers (protein phosphatases), and phosphobinding domains that serve as downstream readers 7 . However, this nomenclature has rarely been used to describe protein phosphorylation cascades in bacteria, where phospho-binding domains are scarce 8 and phosphorylation is thought to mainly directly control the function of specific transcription factors, as exemplified by the two-component regulatory system 9 . With hundreds of phosphoarginine (pArg) sites detected in Bacillus subtilis [10] [11] [12] [13] and Staphylococcus aureus 14, 15 , protein arginine phosphorylation of Gram-positive bacteria is emerging as a novel, major example of a phosphorylation-based signaling system, with established links to stress response and pathogenicity [16] [17] [18] [19] . Arginine side chains are phosphorylated by McsB and dephosphorylated by YwlE, both of which can distinguish (phospho)arginine from other amino acid residues 20, 21 . Although the structure of McsB has remained elusive, sequence analysis has demonstrated that it is unrelated to canonical protein kinases and instead shows weak homology to PhKs, metabolic enzymes exemplified by human creatine kinases and insect arginine kinases [22] [23] [24] . In the species in which it is found, McsB does not have any further sequence homologs and appears to be the only protein arginine kinase, as knocking out its gene abolishes all detectable pArg sites in B. subtilis 11 .
McsB appears to coordinate the stress response in two ways. First, it phosphorylates arginine residues within the DNA-binding domains of CtsR and HrcA, thus directly inhibiting two major negative regulators of the heat-shock response 11, 12, 20 . Relieving the transcriptional repression imposed by CtsR and HrcA induces expression of McsB itself, as well as of the core protein quality control components, including the protease ClpCP and the chaperone DnaK 19 . Second, McsB functions as a 'degradation labeler' , marking both regulatory proteins and aberrant polypeptide molecules for degradation 12 . The phosphorylated substrates are recognized by a pArg-specific reader domain within the ClpCP proteolytic complex. The importance of the pArg-dependent degradation pathway for the bacterial heat-shock response is confirmed by the impaired survival at elevated temperatures of a B. subtilis strain harboring pArg-binding-deficient ClpC 12 . Conceptually, it can be considered a simple bacterial version of the eukaryotic ubiquitin-proteasome system, with the McsB kinase playing a similar role to that of the E3 ubiquitin ligases.
The present study reveals that the protein arginine phosphorylation reaction is catalyzed by the PhK-like catalytic domain of McsB, which is structurally adapted to targeting protein substrates. Moreover, McsB possesses a pArg-binding domain that allows pArg-carrying proteins to allosterically enhance its kinase activity. With the writer McsB, the eraser YwlE, and the pArg reader domains of McsB, CtsR, and ClpC all structurally characterized, the pArg signaling toolkit of Gram-positive bacteria is a phosphosignaling system come of age.
Results
Overall structure of the protein arginine kinase McsB. To exert its biological functions as a transcriptional regulator and a degradation labeler, McsB catalyzes the transfer of the ATP γ-phosphoryl onto the arginine side chain of a protein substrate (Fig. 1a) . For the structural characterization of this distinct protein kinase activity, we determined the crystal structure of McsB from Geobacillus stearothermophilus in the apo state and in complex with an ADP analog, AMP-PN (Fig. 1b-d and Supplementary Table 1) . Crystals were only obtained after deleting the C-terminal residues 356-363, which were predicted to be disordered and are dispensable for in vitro activity ( Supplementary Fig. 1a-c) . Additionally, we used the YwlE protein arginine phosphatase to dephosphorylate pArg sites that accumulated on McsB during expression, owing to autophosphorylation ( Supplementary Fig. 1d ). As seen at high resolution, the McsB dimer adopts a flat 'domino tile' shape (dimensions 120 × 40 × 30 Å), with the two active sites opening on the same side (Fig. 1c) . Individual subunits are composed of the N-terminal catalytic, ATP:guanido phosphotransferase domain (PD, residues 1-263) and the C-terminal dimerization domain (DD, residues 264-355), which are linearly organized in a PD-DD-DD*-PD* manner (asterisk denotes the partner protomer). The PD comprises an antiparallel, nine-stranded β-sheet surrounded by seven α-helices ( Supplementary Fig. 2 ) and at its center contains the active site composed of adjacent binding pockets for Mg-ATP and the guanidino group of the targeted arginine side chain (Fig. 1d) . In our nucleotide-bound structure, the Mg-ATP-binding site shows a clear electron density for AMP-PN ( Supplementary Fig. 3a) . The DD is a four-helix bundle that is tightly associated with the PD.
Enzymatic mechanism of protein arginine phosphorylation. To delineate the molecular mechanism of the protein arginine kinase reaction, we investigated the evolutionary relationship between McsB and PhKs. The PD of McsB shows low sequence homology (~25-30% identity) to the 'large' catalytic domain of PhKs that act on free arginine and creatine 22, 23 . The catalytic mechanism of PhKs primarily depends on the precise stereoelectronic alignment of the reacting γ-phosphoryl and guanidino moieties by a set of properly arranged positively and negatively charged residues [25] [26] [27] [28] . The key residues include five arginine residues coordinating the β-and γ-phosphates of ATP and two glutamate residues and one cysteine residue positioning the guanidino group of the arginine substrate for the phosphoryl transfer 25, 26, 28, 29 . Superposition of the nucleotidebound catalytic domains of McsB and arginine kinase (AK) from the crab Limulus polyphemus 26 showed structural conservation of all eight catalytic residues (Fig. 2a,b) . To test their involvement in McsB-mediated protein arginine phosphorylation, we performed a mutational analysis of a subset of these residues (Arg208, Glu122, Glu213, and Cys168), using β-casein as a model substrate in a quantitative, radioactive kinase assay (Fig. 2c) . Additionally, we applied a 'lag-time' assay that was based on the serendipitous observation that leaky ectopic expression of wild-type (WT) McsB results in a marked growth defect in Escherichia coli. Namely, McsB-expressing cells have an acutely extended lag time, suggesting that the protein arginine kinase activity is toxic in this species (Fig. 2d) . When analyzing the active-site mutations, we consistently observed a normalized growth in the E. coli lag-time assay and a loss of β-casein phosphorylation in the radioactive kinase assay, thus revealing their impaired kinase function (Fig. 2c,d ). In the lag-time assay, the mutations reduced the toxic effect of the McsB kinase without preventing its leaky expression ( Supplementary Fig. 4a,b) . To confirm that the demonstrated lack of activity is caused by an incomplete active site rather than compromised protein stability, we validated the structural integrity of each mutant in thermofluor experiments ( Supplementary Fig. 5a,b) . To further corroborate the mutational analysis data, we developed an in vivo assay monitoring the activity of endogenous McsB in B. subtilis. Because McsB is required for targeting proteins for pArg-dependent degradation, we probed the kinase function by monitoring the stability of its major substrate, CtsR 12, 30 . As predicted by our structural analysis, mutating the catalytic Glu122 (E122A) of the endogenous mcsB stabilized CtsR to an extent comparable to that observed for the mcsB deletion (Fig. 2e) . According to these data, residues implicated in positioning ATP and the arginine side chain in PhKs are essential for the protein phosphorylation activity of McsB in vivo.
We next examined the nucleotide-binding properties of the protein arginine kinase. When superposing apo and AMP-PN-bound McsB subunits, we noticed that, as in PhKs
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, the catalytically competent active site arrangement in McsB was only achieved upon nucleotide binding, which triggered closure of the loop at residues 210-220 (the 'lid') ( Fig. 2f ; electron density maps in Supplementary  Fig. 3b,c) . This conformational change brought Glu213, a lid residue that is part of the conserved catalytic set, close to the predicted reaction site. The importance of the accurate positioning of Glu213 was highlighted by the inactivating effect of the E213D mutation, which changed the length but not the chemical properties of the side chain (Fig. 2c,d ). To further test the relevance of the nucleotide-dependent lid opening and closing, we mutated Tyr211 and His92, two side chains that form different interactions in the open and closed states and thus seem to be involved in the conformational switch (Fig. 2f) . Replacing either of these residues with alanine resulted in a loss of detectable in vitro activity and a normalized growth of E. coli cells in the lag-time assay (Fig. 2c,d ). The impairment of activity was further confirmed in vivo upon introducing a mutation equivalent to Y211A into endogenous mcsB in B. subtilis, which led to robust CtsR stabilization (Fig. 2e) . Together, the in vitro and in vivo results strongly suggest that, despite a large evolutionary distance, McsB and PhKs utilize the same set of catalytic residues to phosphorylate guanidino-containing compounds. The conservation even extends to a defined open-closed conformational switch that yields a functional active site once nucleotide is bound. Thus far, the McsB and PhK active site is the only known catalytic architecture that can catalyze the challenging chemical reaction of guanidino group phosphorylation.
Specificity for protein arginine residues. The observed high degree of structural homology between the active sites of McsB and PhKs raised the question of how these two enzyme classes can modify substrates of different size and complexity (proteins versus small guanidino compounds), thus contributing to distinct biological processes (protein quality control versus energetic homeostasis). Therefore, we next turned our attention to structural differences between McsB and PhKs. In each case, the catalytic domain is accompanied by a different auxiliary domain. Whereas McsB has the C-terminal DD, PhKs possess an N-terminal 'small' domain ( Supplementary Fig. 3a,b) . In PhKs, it is the small domain that defines the specificity toward cognate small molecules 25, 32, 33 and that forms, together with an extended loop-helix-loop motif protruding from the large domain, a dynamic gate to the substratebinding site 34 . Interestingly, these two regions are different in McsB (Supplementary Fig. 3c ). The small domain is absent altogether, and the loop-helix-loop segment (residues 92-105, encompassing helices α2 and α3) is shorter by ten residues. These adaptations remove a major part of the active site boundary, thereby creating sufficient space to accommodate polypeptide substrates ( Supplementary  Fig. 3d ). In agreement with this model, an McsB fusion protein that has the small domain of AK as an additional N-terminal steric block was inactive in the radioactive kinase assay ( Supplementary  Fig. 6e ). It is noteworthy that, although WT McsB did not show any measurable free arginine kinase activity, it was able to phosphorylate short CtsR-derived peptides, as demonstrated using intact MS ( Supplementary Fig. 7a-c c-e, Schematic presentations and results of assays used for mutational analysis: radioactive protein kinase assay (c), lag-time assay (d), and in vivo activity assay (e). In c, the experiment was performed in the presence of 12.5 mM ATP. In d and e, error bars indicate standard deviation for five (for WT in d), three (for control and mutants in d), or four independent experiments (in e); significant differences from WT are marked (*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; two-tailed Student's t test, unpaired in d, paired in e). In e, the quantification shows the amount of CtsR after 60 min relative to the amount after 30 min for a given mutant. Uncropped phosphorimager scan from c is shown in Supplementary Fig. 12a ; full results of d are shown in Supplementary Fig. 4c ; Coomassie staining used as a loading control in e is shown in Supplementary Fig. 12b . f, Top, structural comparison of the apo and the AMP-PN-bound protomer of McsB. Bottom, schematic presentation of lid closure.
with native substrates are expected to be formed primarily with the main chain. However, the sequence of neighboring side chains is likely to have some effect on recruitment efficiency. Because the area around the active site is strongly negatively charged ( Supplementary Fig. 7d ), we hypothesized that McsB might disfavor, through electrostatic repulsion, substrate motifs that contain glutamate or aspartate residues near the arginine phospho-acceptor. In the peptide Ac-KRGGGGYIKIIKV, substituting one or three lysine residues with glutamate residues decreased phosphorylation to undetectable levels ( Supplementary Fig. 7c ). Although this electrostatic filtering is expected to play a role in substrate selection in vivo, it does not seem to completely exclude motifs with negatively charged residues, as these can be found among sites identified in bacteria [10] [11] [12] [13] [14] [15] . Of note, the negatively charged patch bordering the active site entrance may also impact nucleotide binding, as ATP and ADP had relatively weak binding affinities to McsB, reflected in dissociation constant (K D ) values of 262 ± 27 μM and 208 ± 60 μM, respectively ( Supplementary Fig. 8a,b) . Although the exact mechanism of substrate engagement and Michaelis complex formation by McsB remains to be resolved, we conclude that the specificity of McsB for certain proteins and peptides and against isolated arginine is determined by the accessibility of the active site, interactions with the peptide backbone, and electrostatic effects.
Dimerization and putative negative cooperativity. Our crystal structures revealed a dimeric arrangement of McsB (Fig. 1c,d ). The dimer interface runs along helix α8 formed by residues 265-281 and comprises polar interactions between highly conserved residues, such as the Arg273-Glu288* salt bridge and the Phe272-Arg282* cation-π interaction (Fig. 3a) . The conservation of the interface and the large buried surface area of 1,505 Å 2 suggest a stable association, a conclusion that is at variance with a published report describing McsB as a monomer 35 . Because the previous characterization was based on behavior in size-exclusion chromatography (SEC), which provides an indirect estimate of molecular weight (MW), we sought to obtain a more accurate measurement of MW by using native MS ( Fig. 3b and Supplementary Fig. 9 ) and SEC coupled to multiangle light scattering (MALS) (Fig. 3c ). Both methods unequivocally identified the dimer as the predominant oligomeric form of McsB in solution, with tiny amounts of higher oligomers seen in native MS experiments. Moreover, consistent with the interface observed in the crystal structures, dimerization was largely abolished by a charge-reversal mutation of Arg273 (R273E). The narrow charge state distribution in the native MS spectrum of McsB R273E indicates that the monomeric form of McsB is still well folded 36 , as further confirmed by thermofluor and circular dichroism (CD) measurements ( Supplementary Fig. 5a -e). We subsequently tested a series of DD-DD* interface mutants in SEC-MALS ( Fig. 3d and Supplementary Fig. 5f ,g) and in the radioactive kinase assay (Fig. 3e) . Although individual mutations might cause additional effects, the overall tendency for the kinase activity to decline with decreasing dimerization (down to 5-10% of the WT for R273E and R282E mutants) clearly indicates that the association between the two protomers contributes to the activity. To test the implications of this observation in vivo, we introduced a mutation equivalent to R273E into endogenous mcsB in B. subtilis and monitored CtsR degradation. Although CtsR was stabilized ( Fig. 2e ), this effect was less pronounced than what would be predicted from the severe kinase activity impairment seen in vitro. We presume that the McsB reaction is not rate limiting for CtsR degradation and that other factors may affect the oligomeric state or activity of McsB in the cell. Taken together, results from our analysis shows that dimerization, though not strictly necessary for McsB activity, is nonetheless key to achieving its full catalytic potential. Unlike the apo McsB structure, which shows an approximately symmetric dimer, the structure of the AMP-PN-bound state is asymmetric, composed of one liganded and one unliganded subunit (Fig. 1d) . The lid is in the closed conformation in the AMP-PN-bound protomer but in the open conformation is in the empty protomer. The asymmetry of this state further extends to protein dynamicity, with the empty subunit having increased thermal motion (B) factors relative to its nucleotide-bound partner subunit and lacking electron density for three substantial loops (Fig. 3f) . Although asymmetry in crystal structures may reflect packing constraints and should be interpreted with caution, the described features of the AMP-PN-bound McsB might hint at negative cooperativity or, more generally, allosteric communication between the two active sites. If such communication were to promote catalysis, this would explain why dimerization is important for McsB activity, despite being dispensable for stability. In that respect, the observed asymmetry in occupancy and B factors is in line with a mechanism recently proposed for a dimeric model enzyme, fluoroacetate dehalogenase, in which the catalysis in one liganded protomer is facilitated by an increase in disorder in the other empty protomer, which counterweighs entropy losses suffered upon substrate binding 37 . However, whether a similar allosteric mechanism holds true for McsB awaits further experimental investigation. 
The C-terminal DD of McsB contains a pArg-binding pocket.
We next focused our analysis on the structure of the DD, a domain that seemed to be unique to McsB. Surprisingly, its architecture closely resembles that of the C-terminal part of the CtsR transcription factor (Fig. 4a) . Although the overall sequence identity is low (~15%), structure-guided sequence alignments uncovered a shared RDXXRA motif ( Supplementary Fig. 10a ), which forms a surface pocket composed of a positively and negatively charged area. Because this rare bipolar arrangement is reminiscent of that of the recently identified pArg-recognition sites of ClpC 12 , we hypothesized that the DD might bind pArg residues. Indeed, upon soaking McsB crystals with the pArg amino acid, we observed additional electron density in each pocket of the dimer ( Fig. 4b and Supplementary Table 1) . We also obtained a cocrystal structure of the homologous C-terminal domain of CtsR with pArg, thus validating the discovered phospho-receptor site ( Fig. 4c and Supplementary Table 1) . Although the folds of the pArg-binding domains of McsB/CtsR and ClpC are unrelated, they seem to have evolutionarily converged on a similar mode of binding, recognizing the guanidino group via a carboxylic amino acid residue and the phosphoryl group via appropriately spaced positively charged residues and hydrogen bond donors ( Fig. 4d and Supplementary Fig. 10b ). The affinity of McsB for free pArg measured in solution was low (K D = 850 ± 400 μM), but we confirmed that the detected binding was mediated by the identified pocket, as it disappeared in the R338A D339A double mutant affecting the RDXXRA motif ( Supplementary Fig. 8c ). The native ligand is expected to be a pArg-carrying protein, which might form additional interactions and thus bind more tightly. Accordingly, the pArg-binding pockets in McsB and CtsR add to the reader domain of ClpC, suggesting a complex pArg signaling system operative in Gram-positive bacteria.
Putative allosteric control of McsB by pArg polypeptides. Strikingly, the structure of the pArg-bound McsB dimer, although devoid of any nucleotide, showed an asymmetric conformation similar to that for the AMP-PN-bound McsB, with one closed and one open active site and an unequal distribution of B factors ( Fig. 4e and Supplementary Fig. 11 ). According to these structural data, ligand binding to the pArg pocket seems to be communicated to the active site. To test whether pArg binding is involved in allosteric modulation of McsB activity, we monitored β-casein phosphorylation at low ATP concentration, where the reaction is slow and can be resolved in detail by our radioactive kinase assay (Fig. 5a,b) . For WT McsB, the reaction velocity was initially low and only increased after a considerable delay, suggesting that the enzyme is activated by a product that must accumulate above a certain threshold. To test whether the product that activates McsB is the arginine-phosphorylated form of β-casein, we analyzed the kinetics of the pArg-binding-deficient R338A D339A mutant. The mutant, although forming a stable dimer ( Supplementary Fig. 5f,g ), exhibited slow kinetics comparable to the initial velocity of the WT McsB. Strikingly, adding exogenous pArg amino acid to the reaction led to instantaneous activation of the WT McsB but not of the pArg-binding-deficient mutant. These data clearly indicate that the engagement of the pArg pocket is necessary and sufficient to exert stimulation (Fig. 5) . Moreover, it should be noted that our model substrate Supplementary Fig. 12f-h. β-casein naturally contains five exposed phosphoserine residues 38 . Given a delayed boost phase in the absence of the pArg activator (Fig. 5a) , O-phosphorylations are apparently incapable of activating McsB, as would also be expected from the distinct shape and electrostatics of the phospho-binding site.
After seeing the stimulatory effect of free pArg, we next moved to a phospho-peptide as a more relevant effector mimicking interactions with pArg-containing proteins. For this purpose, we used a lysozyme-derived peptide (AWRNRCKGTDVQAWIRGCRL) that could be quantitatively phosphorylated by McsB ( Supplementary  Fig. 7e ). This pArg peptide was efficient in stimulating the kinase activity of McsB (Fig. 5d) . By comparing the initial velocity at various pArg peptide concentrations, we determined the concentration needed to achieve half-maximal activation (EC 50 ) to be 21 ± 9 μM, with as little as 5 μM exerting a substantial, >2-fold increase in rate. The stimulatory efficiency at such low concentration would be expected for a biologically relevant effector molecule. Taken together, our data suggest that the identified pArg-binding pocket is involved in the allosteric control of the enzymatic activity of the McsB kinase, providing regulatory access to pArg-containing effector and substrate proteins.
Discussion
The present study provides the first structural picture of a protein arginine kinase while completing the structural and biochemical analysis of the core pArg writer-eraser-reader toolkit of Grampositive bacteria. We show that McsB catalyzes protein arginine phosphorylation using a domain that is also found in PhKs, animal metabolic enzymes that buffer ATP levels by catalyzing reversible phosphorylation of guanidino compounds. The core active site is remarkably conserved between McsB and PhKs, despite the enormous evolutionary distance separating bacteria from animals. This finding is consistent with previous suggestions that guanidino group phosphorylation is catalyzed primarily by near-perfect alignment of the reacting compounds 25, 26, 39 . Such alignment can only be achieved by a complete set of appropriately positioned residues, leaving little room for evolutionary plasticity at the heart of the enzyme.
Because McsB represents a novel class among protein kinases, we compared it to classic eukaryotic protein kinases that act on serine, threonine, and tyrosine residues (Fig. 6a) . In addition to the particular reliance of McsB on substrate alignment, the crucial difference between the two kinase types lies in the distinct mechanism of activating the reacting residue for phosphotransfer. Whereas the eukaryotic protein kinases typically interact with the substrate's hydroxyl moiety through only one aspartate residue 40, 41 , McsB-like PhKs-employs three negatively charged residues to position and activate the arginine guanidino group for nucleophilic attack on the ATP γ-phosphorus atom.
Although the catalytic core of McsB and PhKs is highly conserved, the two enzyme classes have diverged evolutionarily in another respect. Our comparative analysis demonstrates how structural adaptations in the surroundings of the active site allow McsB and PhKs to target completely different classes of guanidino compounds and, therefore, serve distinct roles in the cell. Whereas PhKs have selectivity filters that accept only specific, small energy-storage compounds, the active site of McsB is accessible to, and actively selects, arginine residues that are part of a polypeptide chain. The McsB-PhK case thus illustrates how new enzymatic and biological functions evolve through preservation of the catalytic properties with concomitant alterations in substrate specificity.
Our study also underscores the role of auxiliary domains in enzyme regulation. By mediating both dimerization and recognition of pArg residues, the DD domain present in McsB but absent from PhKs turns the bacterial protein arginine kinase into an allosteric enzyme, allowing a precise tuning of its catalytic activity (Fig. 6b) . Such regulation seems particularly important for a cellular factor that is central to both the heat-shock response (which involves coordinated launching of protective mechanisms) and protein degradation (where selectivity and timing are key). Specifically, our data suggest that the pArg-binding pocket in the DD mediates the stimulation of the kinase by its products, pArg-carrying proteins or peptides. It is tempting to speculate that in vivo, this mechanism places McsB under two control circuits acting on different time scales: whereas the protein levels of the kinase are under transcriptional control, relying on the McsB-mediated inhibition of the repressor CtsR, the enzyme activity directly reacts to pArg-containing proteins by the identified allosteric mechanism. The two interlinked, positive-feedback loops could together ensure induction of the stress response in a fast but robust manner, as suggested for other feedback systems 42 . Additionally, the uncovered pArg pocket could mediate recruitment of already-phosphorylated substrates for further rounds of phosphorylation. This product stimulation could be important, for example, for efficient marking of large protein aggregates, the preferred in vivo substrates of McsB, as targets for degradation.
The pArg-binding DD of McsB has a homolog in the heat-shock repressor CtsR, and both domains add to the evolutionarily unrelated pArg-binding pocket of ClpC. These new findings underscore the importance of pArg as a signal that can trigger new protein-protein interactions. Indeed, if phospho amino acid residues are well suited for specific recognition by a cognate protein module in general 43 , then the pArg residue, with its zwitterionic nature, extended shape, and ability to both donate and accept multiple hydrogen bonds seems tailor made for this purpose. The relative complexity of the writer-eraser-reader pArg toolkit (Fig. 6c) challenges the established perception that prokaryotic phospho-signaling systems, unlike their eukaryotic counterparts, are generally restricted to simple linear on-off pathways, with little role for phosphorylationdependent protein-protein interactions. This notion was previously suggested by the scarcity of bacterial homologs of known phosphobinding domains, which, except for sporadic cases of horizontal gene transfer, seem limited to phosphothreonine-specific forkheadassociated domains 8 . The identified pArg-binding domains, however, extend the spectrum of known bacterial phospho-binding domains by providing the first examples that go beyond modules known from eukaryotes. Given the important role of the pArg signaling system in virulence of human pathogens such as S. aureus 15, 17 , our structural insights into the writer, eraser, and readers of this modification may facilitate the development of new, much-needed antimicrobial interventions.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41589-019-0265-y. 28 . Pruett, P. S. et al. The putative catalytic bases have, at most, an accessory role in the mechanism of arginine kinase. 12 ), pET21-ywlE-His 6 (ref. 21 ), pET21-mcsBHis 6 (ref. 20 ). Point mutants of full-length mcsB were generated using a standard site-directed mutagenesis protocol. All primers used are listed in Supplementary Table 3 .
Protein expression and purification. Proteins were expressed in an E. coli BL21 (DE3) strain grown in Lysogeny Broth (LB; 10 g NaCl, 5 g yeast extract, 10 g tryptone per liter) containing 50 μg/ml ampicillin. Expression was induced with 0.5 mM IPTG and allowed to proceed for either 12 h at 18 °C (Δ356-363 McsB) or 3 h at 37 °C (other proteins). All proteins were purified on an ÄKTA FPLC system (GE Healthcare Life Sciences). YwlE was purified as described previously 21 . Purification of other proteins was performed with Ni-nitrilotriacetic (Ni-NTA) affinity chromatography in 10 mM Tris, pH 7.5, 150 mM NaCl and increasing imidazole as the first step. For all proteins, except Δ356-363 McsB and Δ1-75 CtsR, Ni-NTA was followed by a Superdex200 size-exclusion column in 10 mM Tris, pH 7.5, 50 mM NaCl. Δ356-363 McsB after Ni-NTA was purified by buffer exchange to 20 mM Tris, pH 8, 50 mM NaCl; dephosphorylation with YwlE (400 μM McsB was mixed with 700 μM YwlE) at room temperature for 1 h; and two chromatography steps for YwlE removal: a Superdex200 size-exclusion column in 50 mM Tris, pH 8, 50 mM NaCl and a Resource Q anion exchange chromatography column in 50 mM Tris, pH 8, 50 mM NaCl and a 50 to 500 mM NaCl gradient. Δ1-75 CtsR post Ni-NTA was purified using a Superdex200 size-exclusion column in 6 mM Na/K phosphate, pH 7.25, 1.35 mM KCl, and 68.5 mM NaCl. Proteins were concentrated using Vivaspin devices (Sartorius). Concentration was determined using Bradford protein assay (Bio-Rad) and/or absorbance at 280 nm.
Dot-blot analysis.
McsB (E122A, WT, or Δ356-363, all at 400 μM) was incubated either alone or with YwlE (at 700 μM) for 1 h at room temperature in 20 mM Tris, pH 8, 50 mM NaCl. Δ356-363 McsB post Ni-NTA (without dephosphorylation) was used. Two microliters of each sample was pipetted onto a nitrocellulose membrane. The membrane was blocked with 3% bovine serum albumin (BSA) in TBS (50 mM Tris, pH 7.5, 150 mM NaCl) and immunoblotted with the 2 μg/ml human F (ab')2 anti-pArg primary antibody 21 , then a 1:7,000 dilution of horseradish peroxidase (HRP)-coupled anti-human IgG F (ab')2 antibody (AbD Serotec, now Bio-Rad, cat. no. STAR126). The signal was visualized using the Clarity enhanced chemiluminescence (ECL) reagent (Bio-Rad).
Crystallization, data collection, structure solution, refinement, and analysis. Monoclinic Δ356-363 McsB crystals were obtained within 3 d at 4 °C via sittingdrop vapor diffusion upon mixing 100 nl of the optimized Morpheus screen (Molecular Dimensions) solution (25% v/v ethylene glycol, 75 mM MES-imidazole, pH 6.2, and 58 mM of each of the following: Na formate, NH 4 acetate, Na citrate, Na K tartrate, Na oxamate) with 200 nl of protein solution containing 480 μM Δ356-363 McsB in 50 mM Tris, pH 8, 240 mM NaCl supplemented with 1 mM Tris(2-carboxyethyl)phosphine (TCEP). Soaking was performed by incubation with ligand (2 mM pArg, Sigma-Aldrich, or 10 mM MgCl 2 and 10 mM AMP-PNP, Jena Bioscience) dissolved in the reservoir solution supplemented with 1 mM TCEP. McsB crystals were cryoprotected in 40% v/v PEG 400 and 60% reservoir solution supplemented with, for the soaked crystals, the matching ligand. Electron density analysis demonstrates that AMP-PNP hydrolyzed in the slightly acidic crystallization condition to an ADP analog, AMP-PN.
Orthorhombic Δ1-75 CtsR-pArg crystals formed within 3 d at 19 °C by the same technique upon mixing 100 nl of 10% v/v polypropylene glycol P 400 with 200 nl of protein solution containing 2.4 mM Δ1-75 CtsR in 6 mM Na/K phosphate, pH 7.25, 1.35 mM KCl, 68.5 mM NaCl, 5 mM pArg. CtsR crystals were cryoprotected in 40% PEG 400, 6 mM pArg, 6 mM Tris, pH 7.5, 90 mM NaCl. Diffraction data were collected at 100 K at beamlines: ID23-1 (McsB) and ID23-2 (McsB-AMP-PN) at ESRF, Grenoble; P13 at DESY, Hamburg 44 (McsBpArg); and at an in-house Rigaku X-ray generator (Δ1-75 CtsR-pArg). The wavelengths used were 0.979 Å, 0.873 Å, 0.976 Å, and 1.542 Å, respectively. All data were integrated and scaled using XDS 45 . For McsB, an initial low-confidence molecular replacement solution obtained with Phaser 46 using a fragment of PDB 1M15 as a search model was improved by iterative manual and automatic rebuilding with O 47 , Coot 48 , and ARP/wARP 49 . Ligand-bound McsB structures were solved via molecular replacement in Phaser using the final apo model, followed by rebuilding and ligand placing in Coot. The Δ1-75 CtsR-pArg structure was solved via molecular replacement in Phaser using a fragment of PDB 3H0D as a search model and further rebuilding and ligand placing in Coot. All structures were refined with CNS 50 and PHENIX 51 to good Ramachandran statistics with Table 1 . PyMOL (Schrodinger) was used for figure preparation.
Sequence and structure alignments. Sequence alignment of C-terminal regions of McsBs from various Bacillus species was performed using MAFFT 7 (ref. 52 ). Structure-guided sequence alignment of C-terminal regions of selected McsB and CtsR proteins from Bacillus species was performed using PROMALS3D 53 . Structure superpositions were performed in PyMOL (Schrodinger), and r.m.s. deviation calculations were performed with SuperPose version 1.0 (ref. 54 ).
Radioactive protein kinase assay. All experiments except for those shown in Fig. 5c,d consisted of a single step in which 55 μM β-casein (Sigma-Aldrich) was incubated with 0.5 μM McsB and either 200 μM (for experiment illustrated in Fig. 5a,b) , or 12.5 mM ATP (for all other experiments) spiked with [γ-32 P]ATP from Perkin Elmer for the indicated time periods at 37 °C in 55 mM Tris, pH 7.5, 55 mM NaCl, 2% glycerol, 10 mM β-mercaptoethanol, and 12.5 mM MgCl 2 . In the experiment shown in Fig. 5a ,b, 10 mM phosphoarginine (Sigma-Aldrich) was added to indicated samples. The reaction was stopped by adding denaturing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. After resolving the samples on a 15% SDS-PAGE gel, radioactive signal was visualized using a phosphorimager (GE Healthcare Life Sciences). Bands from phosphorimager scans were quantified using ImageJ (NIH). To average results obtained from different repeats of the same radioactive kinase assay experiment, the volumes of all bands were expressed as fractions of the volume of the band for the final time point of the WT sample (in the experiment shown in Fig. 5 , specifically: WT sample without pArg) in the same scan, which was treated as one arbitrary unit.
The experiment illustrated in Fig. 5c ,d was performed in two steps. In the first step, 1.1 mM of peptide (AWRNRCKGTDVQAWIRGCRL), as well as a control reaction in the absence of the peptide, was incubated with 2.5 µM McsB, 333 µM ATP, 12.5 mM MgCl 2 , 10 mM phosphoenolpyruvate, 10 U/ml pyruvate kinase (Sigma-Aldrich) and 10 mM KCl in 50 µl of 55 mM Tris, pH 7.5, 55 mM NaCl, 2% glycerol, 10 mM β-mercaptoethanol for 2 h at 37 °C. McsB was removed from both reactions using Spin Cup columns (Pierce) packed with 50 µl (25 µg) Ni-NTA Superflow beads (Qiagen). The peptide reaction was analyzed using intact MS to confirm phosphorylation ( Supplementary Fig. 7e ). In the second step, the two reactions were first mixed in an appropriate ratio, depending on the desired peptide concentration, and then diluted five-fold with the reaction buffer containing a fresh supply of McsB. The reactions were started with the addition of β-casein substrate spiked with [γ-32 P]ATP (Perkin Elmer). The final reactions contained 0.5 µM McsB, 55 μM β-casein, 50 µM ATP spiked with hot ATP, 12.5 mM MgCl 2 , 2 mM phosphoenolpyruvate, 2 U/ml pyruvate kinase, and 2 mM KCl in reaction buffer. The use of the ATP regeneration system results in diluting of hot ATP (which is not regenerated) with cold ATP (which is) over time, but this should occur in the same way in all samples, regardless of peptide concentration. In the experiment shown in Fig. 5d , β-casein phosphorylation at 25 min, which is within the linear reaction phase according to data shown in Fig. 5c , was used to estimate relative reaction rate for increasing peptide pArg concentrations. Three-parameter agonist versus response curves were fitted individually to each data series using Prism version 7.04 (GraphPad), and the obtained EC 50 values were averaged.
Bacterial culture growth conditions. All bacterial strains used (Supplementary  Table 4 ) were cultivated either on plates with LB solidified with 1.5% (w/v) agar or under vigorous agitation in liquid culture, in both cases, unless otherwise stated, at 37 °C. For liquid culture, we used LB or a modified version of a previously described synthetic medium 55 Bacterial strains. The B. subtilis strains described in Supplementary Table 4 as from 'this study' were generated by introducing mutations to the chromosome of the laboratory strain 168 of B. subtilis using the pMAD vector-based protocol 56 . First, two 2-Kb-long fragments of chromosomal DNA that span the 5′-and 3′-end halves of the mcsB gene were cloned separately into a pMAD vector, yielding plasmids pMAD-mcsB Nterm and pMAD-mcsB Cterm , respectively. This was then followed by Q5 site-directed mutagenesis (New England Biolabs) of the vector best suited for a given point mutation, integration into B. subtilis 168, and curing of the vector. The mcsB deletion strain (Δmcsb) was produced by mutating the third codon of mcsB into a stop codon using the same technique.
Serum and antibody generation. Serum against B. subtilis CtsR and B. subtilis
McsB were produced in collaboration with Gramsch laboratories by injecting recombinant protein into rabbits. Polyclonal anti-McsB antibody was produced by purifying the latter serum using an N-hydroxysuccinimide (NHS)-coupled resin (GE Healthcare Life Sciences) charged with McsB. After washing with PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 ), the antibody was eluted with 100 mM glycine, pH 2.6, pH adjusted, and dialyzed into PBS supplemented with 10% glycerol.
Lag-time assay. The experiment was performed in LB containing 50 μg/ml ampicillin at 37 °C. A set of pET21 plasmids harboring a control gene (encoding the fragment 1-150 of ClpA from E. coli), WT mcsB, or one of various point mutants of full-length mcsB were individually transformed into chemically competent E. coli BL21 (DE3) cells. Five-milliliter cultures were grown in roundbottom Falcon tubes (Corning) for ~12 h, until the OD 600 of at least 1 AU. If this high density was not achieved, the growth-impairing effect of mcsB was less pronounced. The overnight cultures were each diluted into 5 ml of fresh medium to the calculated OD 600 of 0.0045. The OD 600 was then measured at regular time intervals using a small-volume spectrophotometer/fluorimeter DS-11 FX+ (DeNovix). Measured growth curves were fitted to the three-parameter 'modified logistic equation' 57 given below by minimizing squared errors between actual and predicted values using Excel Solver tool (Microsoft).
Modified logistic equation:
where d(t) is the OD 600 at time t; A is a maximal density (allowed to be different for each curve, but between 0.9 and 2, which were minimal and maximal OD 600 values, respectively, of test cultures after prolonged, overnight cultivation); λ is lag time (allowed to be different for each curve); and μ is maximal growth rate (forced to be the same for all fitted curves). λ was a robust parameter that did not change significantly with A or μ. We used the unpaired two-tailed Student's t test to test the null hypothesis that the λ values measured for a mutant are not different from those for WT. To verify McsB expression levels, cell pellets from 1.5-ml cultures at OD 600 of 0.3 were lysed in 40 μl of B-PER solution (ThermoFisher Scientific) containing 50 μg/ml lysozyme (Sigma-Aldrich) and 1 μg/ml DNase I (Roche). The lysates were separated on a 15% SDS-PAGE gel, transferred onto a polyvinylidene difluoride (PVDF) membrane (Thermo Fisher Scientific), and immunoblotted according to a standard protocol with a 1:5,000 dilution of anti-McsB antibody generated in this study or a 1:1,000 dilution of a penta-His-tag mouse monoclonal antibody (Qiagen, cat. no. 34660). The signal was visualized using 1:10,000 dilution of an HPR-coupled anti-rabbit (Sigma-Aldrich, cat. no. A0545) or anti-mouse (Jackson ImmunoResearch, cat. no. 115-035-003) secondary antibody and Clarity ECL reagent (Bio-Rad).
Thermofluor/differential scanning fluorimetry assay. Protein stability of various McsB mutants were investigated using thermofluor/differential scanning fluorimetry. The reaction mixture consisted of 0.05 mg/ml protein under study and 7.5× SYPRO orange (Thermo Fisher) in 55 mM Tris-HCl, pH 7.5, 55 mM NaCl, 2% v/v glycerol, 10 mM β-mercaptoethanol and 12.5 mM MgCl 2 in a final volume of 20 µl. Melting curves were monitored with a Bio-Rad CFX96 thermal cycler, and fluorescence signals were obtained using the FRET channel. The thermal cycling protocol consisted of equilibration at 25 °C for 1 min and subsequent fluorescence measurement. The next steps included heating by 1 °C, then 1-min equilibration and fluorescence measurement until 95 °C. Melting curve analysis was performed using a previously reported Excel-based (Microsoft) software 58 .
In vivo McsB activity assay. The experiment was performed in round-bottom Falcon tubes (Corning) in synthetic medium. Two or three middle-sized colonies of the B. subtilis strains 168, ΔmcsB, mcsB E121A , mcsB Y210A , and mcsB R272E from an overnight culture were each cultivated in 5 ml of the medium for 2 h to adapt to its composition, prior to being diluted to the OD 600 of 0.075 in the total volume of 6 ml. At the OD 600 of 0.5, the cultures were moved to a shaker that was prewarmed to 50 °C. One-milliliter samples were taken at indicated time intervals. Cells were harvested via centrifugation, and the pellets were lysed in 40 μl of B-PER solution (Thermo Fisher Scientific) supplemented with 50 μg/ml lysozyme (SigmaAldrich) and 1 μg/ml DNase I (Roche). The lysates were separated on a 15% SDS-PAGE gel, transferred onto a PVDF membrane (Thermo Fisher Scientific), and immunoblotted using a standard protocol with 1:2,000 dilution of anti-CtsR rabbit serum. The signal was visualized using a 1:10,000 dilution of an HPR-coupled anti-rabbit secondary antibody (Sigma-Aldrich, cat. no. A0545) and Clarity ECL reagent (Bio-Rad). The tested B. subtilis McsB residues are referred to in Fig. 2e using G. stearothermophilus McsB residue numbering. Bands from immunoblots were quantified using ImageJ (NIH).
Free arginine kinase assay. We monitored free arginine kinase activity indirectly by measuring the rate of ADP generation in the presence of arginine using a coupled enzymatic reaction 59 . 1.5 µM full-length McsB or arginine kinase with or without 25 mM arginine was incubated at 25 °C with 37.5 U/ml pyruvate kinase, 42.9 U/ml lactate dehydrogenase, 0.25 mM NADH, 15 mM phosphoenolpyruvate, and 0.5 mM ATP in ATPase buffer (20 mM HEPES, pH 7.75, 100 mM NaCl, 15 mM KCl, 5 mM MgCl 2 ). Absorbance at 340 nm was recorded for 14 min using PHERAstar FS plate reader (BMG Labtech). ADP generation rate was calculated as described previously 60 .
Arginine phosphorylation and intact mass spectrometry of peptides. Two N-terminally acetylated CtsR-derived sequences, Ac-KRGGGGYIKIIKV and Ac-YKVKSKRGGGGY, and two mutated versions of the first sequence (Ac-KRGGGGYIEIIKV and Ac-KRGGGGYIEIIEV), were tested. 100 μM peptide was incubated with 0.5 µM McsB in the presence of 12.5 mM ATP at 37 °C for 2 h in a buffer containing 55 mM Tris, pH 7.5, 55 mM NaCl, 1 mM TCEP, and 12.5 mM MgCl 2 . Subsequently, McsB was removed from the reactions using Spin Cup columns (Pierce) packed with 30 µl (15 µg) Ni-NTA Superflow beads (Qiagen). The flow through was collected and used for a desalting protocol using C18 spin tips prior to intact MS analysis. The peptides were eluted twice using 20 µl 80% acetonitrile and used for intact MS.
Intact MS of peptides was carried out on a Synapt G2Si instrument (Waters) with a nanoelectrospray ionization (nESI) source. Mass calibration was performed using a separate infusion of NaI cluster ions. Solutions were ionized through a positive potential applied to metal-coated borosilicate capillaries (ThermoFisher Scientific). Peptides were sprayed from 40% acetonitrile at a concentration of 10 μM. Capillary voltage, sample cone voltage, extractor source offset, and source temperature were set to 1.5 kV, 30 V, 20 V and 40 °C, respectively. Data were processed using MassLynx software version 4.1 (Waters).
Surface plasmon resonance. Surface plasmon resonance measurements were performed on a Biacore T200 instrument (GE Healthcare Life Sciences) at 25 °C. Full-length McsB was immobilized (11,800 resonance units) by capture-coupling to a Ni-loaded NTA Chip (GE Healthcare Life Sciences) by passing 4.8 μM (200 μg/ ml) protein at a flow rate of 10 µl/min in 10 mM HEPES, pH 7.4, 150 mM NaCl, and 0.05% v/v surfactant P20 for a contact time of 300 s over the surface. Binding of ligands was probed by performing a ten-point titration (1:1 dilution steps), starting with either 2 mM (for ADP) or 1 mM (for pArg and ATP) ligand as the maximal concentration. For each titration point, the ligand was passed over the chip at a flow rate of 30 µl/min in 25 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , and 0.005% Tween-20 for a contact time of 60 s and was subsequently washed away with buffer for a dissociation time of 120 s. Obtained sensorgrams were blank subtracted. Dissociation constants (K D ) were calculated using the Langmuir fit model of the BIAevaluation Software version 2.0 (GE Healthcare Life Sciences) from a plot of steady-state binding levels (obtained 5 s before the end of each injection at steady state) against ligand concentration, assuming 1:1 binding stoichiometry.
Size-exclusion chromatography-multiangle light scattering. SEC-MALS analysis of 25 μl full-length McsB samples at ~100 μM (~4 mg/ml) was performed using a Superdex200 increase 5/150 GL column installed on an ÄKTA ETTAN LC system (GE Healthcare Life Sciences) and equilibrated in 50 mM Tris, pH 7.5, 50 mM NaCl. A flow rate of 0.33 ml/min was used. The column was connected to a miniDAWN TREOS light scattering detector (Wyatt Technologies). Average molecular mass across the central parts of main peaks was calculated using ASTRA software v6 (Wyatt Technologies).
Native mass spectrometry. Native MS experiments were carried out on a Synapt G2Si instrument (Waters) equipped with a nanoelectrospray ionization (nESI) source. Mass calibration was performed using a separate infusion of NaI cluster ions. Solutions were ionized through a positive potential applied to metal-coated borosilicate capillaries (Thermo Fisher Scientific). Full-length McsB samples (5 μM) were sprayed from 100 mM ammonium acetate, pH 7.85. During the observation of the multimeric state, the following parameters were used: capillary voltage, 1.6 kV; sample cone voltage, 60 V; extractor source offset, 80 V; source temperature, 70 °C. Data were processed using MassLynx software version 4.1 (Waters). Circular dichroism. Raw ellipticity (θ) of 4 μM (0.17 mg/ml) WT or R273E full-length McsB in 50 mM Na phosphate, pH 7.52, 50 mM was recorded over a range of wavelengths (260-195 nm) at increasing temperatures (20-90 °C, 1 °C per step, 1 °C per min heating rate) using a Chirascan-plus Circular Dichroism Spectrometer (Applied Photophysics) and Chirascan Single Cell Peltier Temperature Controller (Applied Photophysics). The temperature was monitored with a thermal probe placed in the cuvette. θ values for R273E McsB were scaled by a factor of 1.26 (the ratio of absorption values measured at 205 nm for WT and R273E McsB) to account for error in initial protein concentration estimation. Spectra obtained at a range of temperatures were deconvoluted using the Global 3 software (Applied Photophysics) into a linear combination of 'folded' and 'unfolded' spectra to estimate the percentage of unfolded state at each temperature and, by fitting a sigmoidal curve, the midpoint of transition temperatures (T m ).
Statistical analysis. Data analysis in X-ray crystallography, SEC-MALS, native MS, CD, surface plasmon resonance, and EC 50 calculations from the radioactive kinase assay measurements was performed using standard specialized software outlined above. All additional statistical calculations were performed in Excel (Microsoft) with details, such as n values, the type of replicates, and the test used indicated in the figure legends. In bar graphs, the bar represents the mean, dots indicated individual measurements, and error bars indicated standard deviation. The significance of difference between sets of measurements was assessed using two-tailed Student's t test (T.TEST function in Excel), either unpaired or paired, as 1 nature research | reporting summary 
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Data collection
MxCuBE software (versions available at the beamline at the times of collection) at crystallographi beamlines and mar345 (marXperts) program in-house were used for crystallographic data collection. Typhoon Scanner Trio Control Software was used for obtaining Phosphorimager scans. DeNovix DS-11 software (v3.35) was used for OD measurements. Image Lab Software (v6.0.1) was used for visualising immunoblots. CFX manager (v3.1) was used for thermofluor measurements. Reader Control Software was used to operate PHERAstart during free arginine kinase assay. Control software for Synapt G2Si instrument was used for mass spectrometry data collection. Biacore T200 Control Software was used for SPR data collection. UNICORN (v5 and 6) and ASTRA (v6) were used for SEC and MALLS, respectively. Chirascan software accompanying Chriascan-plus model was used for CD data collection.
Data analysis
Crystallographic data analysis was performed with PHENIX (version 1.14, including AutoBuild), CCP4 (version 7.0, including ARP/wARP and Phaser), XDS (versions 2017 and 2018), CNS (version 1.3), O (v. 13), Coot (v. 0.8), and PyMOL (version 1.6). Prism (version 7.04), BIAevaluation (version 2.0), and Excel (version 2016) were used for curve fitting, as detailed in Methods section. ImageJ was used for band quantification. MassLynx (version 4.1) was used for mass spectrometry data analysis. ASTRA (version 6.0) was used for SEC-MALS data acquisition and analysis. GLOBAL (v. 3) was used for CD data analysis. MAFFT7, PROMALS3D, and SuprPose (v. 1) were used for sequence and structure alignments. Adobe Illustrator and Photoshop (v. CS6) were used for final figure preparation.
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